In late 2020, the US Food and Drug Administration (FDA) approved plasma kallikrein inhibitor berotralstat, making it the first oral, once-a-day treatment available for the
Read more
Home »
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GOPTEN trandolapril Consumer Medicine Information What is in this leaflet This leaflet
Read more
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. BREVINOR-1® 28 DAY Ethinylestradiol and Norethisterone Consumer Medicine Information What is in
Read more